WEKO3
アイテム
{"_buckets": {"deposit": "143d4afa-3648-4a6e-baf7-f5ce761ed63f"}, "_deposit": {"created_by": 1, "id": "46511", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "46511"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00046511", "sets": ["1"]}, "author_link": ["463502", "463503", "463504", "463499", "463498", "463496", "463500", "463497", "463501", "463506", "463505"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2012-09", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "9", "bibliographicPageEnd": "4018", "bibliographicPageStart": "4013", "bibliographicVolumeNumber": "32", "bibliographic_titles": [{"bibliographic_title": "Anticancer Research"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Aim: To evaluate the value of hyperfractionated radiotherapy with concurrent use of low-dose docetaxel in locally-advanced head and neck squamous cell cancer (HNSCC). Patients and Methods: Patients eligible for this study had confirmed diagnosis of HNSCC stages II (\u003e10 cm3) to IVB. Radiotherapy was delivered twice daily at 1.2 Gy/fraction to a total dose of 72.0 Gy. Docetaxel (10 mg/m2) was administered weekly during radiotherapy. Results: From March 2003 to October 2008, 70 patients were treated. Primary sites included the oropharynx (n=25), hypopharynx (n=24), larynx (n=18), and other sites (n=3). Major grade 3 acute toxicities included mucositis (n=43) and treatment-related pain (n=20). The median follow-up period for surviving patients was 43 months. The 5-year local control rate and overall survival rate were 62.6% and 61.6%, respectively. Conclusion: This modality is a valuable treatment option for the management of locally-advanced HNSCC.", "subitem_description_type": "Abstract"}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0250-7005", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Karasawa, Kumiko"}], "nameIdentifiers": [{"nameIdentifier": "463496", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Matsumoto, Fumihiko"}], "nameIdentifiers": [{"nameIdentifier": "463497", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ito, Shin"}], "nameIdentifiers": [{"nameIdentifier": "463498", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Oba, Shinichi"}], "nameIdentifiers": [{"nameIdentifier": "463499", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Furuya, Tomohisa"}], "nameIdentifiers": [{"nameIdentifier": "463500", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hirowatari, Hisako"}], "nameIdentifiers": [{"nameIdentifier": "463501", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Izawa, Hiromi"}], "nameIdentifiers": [{"nameIdentifier": "463502", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ito, Kana"}], "nameIdentifiers": [{"nameIdentifier": "463503", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sasai, Keisuke"}], "nameIdentifiers": [{"nameIdentifier": "463504", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "唐澤 久美子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "463505", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "笹井 啓資", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "463506", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/46511", "pubdate": {"attribute_name": "公開日", "attribute_value": "2013-03-28"}, "publish_date": "2013-03-28", "publish_status": "0", "recid": "46511", "relation": {}, "relation_version_is_last": true, "title": ["Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study"], "weko_shared_id": -1}
Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study
https://repo.qst.go.jp/records/46511
https://repo.qst.go.jp/records/46511641d4e36-c65e-4662-9f53-d267fea88eb8
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2013-03-28 | |||||
タイトル | ||||||
タイトル | Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Karasawa, Kumiko
× Karasawa, Kumiko× Matsumoto, Fumihiko× Ito, Shin× Oba, Shinichi× Furuya, Tomohisa× Hirowatari, Hisako× Izawa, Hiromi× Ito, Kana× Sasai, Keisuke× 唐澤 久美子× 笹井 啓資 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Aim: To evaluate the value of hyperfractionated radiotherapy with concurrent use of low-dose docetaxel in locally-advanced head and neck squamous cell cancer (HNSCC). Patients and Methods: Patients eligible for this study had confirmed diagnosis of HNSCC stages II (>10 cm3) to IVB. Radiotherapy was delivered twice daily at 1.2 Gy/fraction to a total dose of 72.0 Gy. Docetaxel (10 mg/m2) was administered weekly during radiotherapy. Results: From March 2003 to October 2008, 70 patients were treated. Primary sites included the oropharynx (n=25), hypopharynx (n=24), larynx (n=18), and other sites (n=3). Major grade 3 acute toxicities included mucositis (n=43) and treatment-related pain (n=20). The median follow-up period for surviving patients was 43 months. The 5-year local control rate and overall survival rate were 62.6% and 61.6%, respectively. Conclusion: This modality is a valuable treatment option for the management of locally-advanced HNSCC. | |||||
書誌情報 |
Anticancer Research 巻 32, 号 9, p. 4013-4018, 発行日 2012-09 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0250-7005 |